History
We believe that T cells will shape the future of medicine. That is why we want to help accelerate the development of therapeutics and diagnostics that leverage their power. To do this we develop AI-based models that give you unique and predictive insights in T cell response.
ImmuneWatch is a spin-off company born from years of collaboration between clinicians and data scientists at the University of Antwerp and Antwerp University Hospital in Belgium. We have founded ImmuneWatch to bring our innovations closer to patients and make a real difference in their lives.
A detailed overview of relevant scientific papers published by the founding team can be found here.
TEAM
CEO
Sander Wuyts, PhD
Entrepreneur and PhD in Bioscience Engineering with speciality in bioinformatics
Got his 10 minutes of worldwide fame when he found a bitcoin in synthetic DNA.
CTO
Pieter Meysman, PhD
PhD in Bioscience Engineering with speciality in machine learning and immunoinformatics.
Chan Zuckerberg-initiative grantee for T-cell bioinformatics
Scientific Director
prof. Kris Laukens, PhD
Professor in bioinformatics and biodata mining at Laukens lab.
Winner of the AstraZeneca Foundation 2021 Award for his work on heterogeneity of immune defenses to infections.
Medical Director
prof. Benson Ogunjimi, MD, PhD
Associate Professor in Translational Immunology and paediatric rheumatologist at the Antwerp University Hospital
ERC Starting Grant awardee for modelling population T-cell responses
Connect with us!
Business [at] immunewatch.com
Copyright © 2021 ImmuneWatch BV. ImmuneWatch is a registered trademark.
ImmuneWatch BV | BE0774.472.942 | Lange Gasthuisstraat 29-31, 2000, Antwerp, Belgium